About the Campaign
The Campaign for Patient Access was launched by the American College of Cardiology in December 2009 as a national effort to reverse Medicare physician fee schedule cuts that threatened cardiovascular care. The site provided background on the issue, the ACC's legislative and legal response, resources for patients and practices, a newsroom tracking coverage across the country, and ways for supporters to share their stories and support the campaign.
From the Newsroom
Medicare Meltdown: Access to Health Care in "Critical Condition"
A press release warning that cardiology access was in critical condition due to Medicare payment cuts.
Read more
Cardiology Takes Legal Action Against Medicare
The ACC filed suit against HHS Secretary Kathleen Sebelius over the 2010 Physician Fee Schedule.
Read more
ACC Statement on Health Care Reform
The ACC used the State of the Union address to highlight the need to reverse the Medicare cuts.
Read more
Medicare Patients and Physicians Join Petition Drive
Patients and physicians in Washington, DC joined a petition drive calling on Congress for Medicare reform.
Read moreHow reduced reimbursement threatens preventive cardiology screenings
Preventive cardiology depends on finding risk before it becomes an emergency. Blood pressure checks, cholesterol testing, diabetes screening, cardiovascular risk assessments, and follow-up counseling can identify patients who need treatment years before a heart attack or stroke occurs. These services may appear routine, but they require time, trained staff, clinical judgment, and reliable payment.
When Medicare physician reimbursement declines, practices must make difficult decisions about how to use limited resources. A screening appointment may generate less revenue than a complex procedure, even though early detection can prevent costly hospitalizations and irreversible disability. Over time, reduced reimbursement can make preventive work harder to schedule, staff, and sustain.
The effects are especially serious in communities where patients already face transportation barriers, limited specialist availability, high rates of diabetes or hypertension, and fewer primary care resources. Reduced reimbursement threatens preventive cardiology screenings by weakening the financial foundation that allows practices to offer them consistently.
Why prevention depends on reliable payment
Screening is more than a single test. A cardiovascular risk visit may include a detailed medical history, medication review, blood pressure measurement, family history assessment, laboratory orders, lifestyle counseling, and a plan for follow-up. Clinicians may also need to interpret results in light of kidney disease, pregnancy history, age, ethnicity, or other conditions.
Those activities require time that cannot always be compressed into a brief appointment. A cardiologist or primary care physician must explain why elevated cholesterol matters, discuss statin benefits and risks, review home blood pressure readings, and help a patient choose realistic changes. When payment does not reflect that work, practices may have less capacity for appointments devoted to prevention.
Stable reimbursement also supports the infrastructure behind screening. Nurses and medical assistants prepare patients, coordinate laboratory testing, contact people about abnormal results, and arrange referrals. Electronic health record systems track overdue screenings and preventive care gaps. If payment reductions lead to staff cuts, these supporting functions may disappear before patients notice the financial strain directly.
What lower reimbursement changes in daily practice
A practice facing a Medicare fee schedule cut may respond by shortening visits, limiting new-patient appointments, or shifting staff toward services with stronger margins. Some offices may reduce dedicated prevention clinics or stop offering extended cardiovascular risk consultations. Others may find that they cannot afford the personnel needed to call patients back, monitor treatment, or coordinate care with primary physicians.
The pressure can also affect the range of services available in one location. A patient might receive a blood pressure check but lack time for a full risk assessment. A lipid result may be reported without a meaningful discussion of treatment. A patient with an abnormal result may wait weeks for follow-up because the practice has fewer appointment slots and less administrative support.
These changes are rarely announced as the elimination of prevention. Instead, access erodes through longer waits, fewer outreach calls, reduced evening hours, and narrower eligibility for appointments. Patients who need the most guidance may be least able to navigate a fragmented system or pay privately for additional counseling.
Patients most exposed to access gaps
Reduced reimbursement does not affect every patient equally. People with private insurance, flexible work schedules, transportation, and the ability to travel may find alternatives. Medicare beneficiaries in rural or underserved areas often have fewer choices. If the nearest cardiology practice stops accepting new patients or reduces preventive visits, the next available clinician may be many miles away.
Older adults frequently have multiple conditions that make cardiovascular prevention more complex. Diabetes, chronic kidney disease, obesity, peripheral artery disease, and prior tobacco use can alter risk calculations and treatment decisions. These patients benefit from careful coordination, yet they are also more likely to need longer visits and repeated monitoring.
Racial and ethnic disparities can widen when screening capacity contracts. Communities that already experience higher rates of uncontrolled hypertension, diabetes, and cardiovascular disease may lose access to trusted clinicians and convenient testing. A lower rate of screening can then lead to later diagnoses, more severe disease, and greater reliance on emergency care.
The clinical costs appear later
The financial effects of a reimbursement cut may be visible immediately in a practice budget, but the clinical consequences often emerge months or years later. Undiagnosed high blood pressure can damage the heart, kidneys, brain, and blood vessels. Untreated high cholesterol can accelerate atherosclerosis without causing symptoms. Missed diabetes screening can delay treatment during a period when lifestyle and medication interventions may be most effective.
Preventive cardiology also depends on continuity. A single normal blood pressure reading does not remove future risk, and one cholesterol test may not reflect changing health conditions. Patients need periodic reassessment, medication adjustments, and reinforcement of healthy behaviors. When follow-up becomes difficult to obtain, early warning signs can be missed.
Emergency treatment is often far more expensive than prevention, but cost comparisons alone do not capture the human impact. A preventable heart attack can result in lost income, disability, depression, caregiver strain, and reduced quality of life. Protecting screening capacity is therefore a clinical priority as well as a responsible use of public funds.
| Preventive service | What it can identify | How reimbursement pressure can affect access |
|---|---|---|
| Blood pressure screening and follow-up | Hypertension and related organ risk | Shorter visits and less monitoring |
| Cholesterol testing and risk assessment | Atherosclerotic cardiovascular disease risk | Fewer counseling appointments and delayed treatment |
| Diabetes screening | Elevated glucose and metabolic risk | Reduced outreach and missed laboratory follow-up |
| Family and personal history review | Inherited or established cardiovascular risk | Less time for individualized prevention plans |
| Coronary artery calcium assessment when appropriate | Evidence of coronary plaque burden | Fewer specialist consultations to interpret results |
| Lifestyle and medication counseling | Modifiable risk factors and adherence barriers | Limited education and weaker continuity of care |
Payment policy shapes clinical availability
Medicare reimbursement policy influences whether practices can continue offering services that are essential but difficult to deliver efficiently. Physician fee schedule cuts may be intended as budgetary adjustments, yet their practical effect can be a gradual shift away from labor-intensive prevention. The result is a payment system that rewards treating advanced disease more reliably than preventing it.
Policy discussions should account for the full value of cardiovascular screening. A reimbursement formula that recognizes evaluation, counseling, care coordination, and follow-up can help practices maintain preventive services. Payment models can also support team-based care, allowing nurses, pharmacists, and other qualified professionals to contribute under appropriate physician supervision.
Professional organizations, clinicians, and patients have an important role in documenting what happens when payment falls short. Stories about canceled screening clinics, extended waits, practice closures, and lost follow-up provide evidence that spreadsheets may miss. Public advocacy can connect those experiences to broader decisions about Medicare physician payment and access to care.
Practical priorities for preserving screening capacity
A strong response should focus on measures that keep prevention available while improving accountability for results. Health systems and policymakers can:
- Protect reimbursement for comprehensive cardiovascular risk assessment, counseling, and follow-up.
- Support team-based preventive care so nurses, pharmacists, and educators can extend clinical capacity.
- Track screening rates, appointment delays, and geographic access after payment changes.
- Preserve incentives for reaching patients with hypertension, diabetes, high cholesterol, or tobacco exposure.
- Include patient and clinician experiences in evaluations of Medicare payment policy.
Practices can also use registries and electronic reminders to identify patients who are overdue for screening. Group education, remote blood pressure monitoring, and coordinated laboratory visits may help extend resources, but these tools still require staffing and investment. Technology cannot replace payment that covers the professional work of interpreting results and making a safe plan.
Patients and physicians should be able to explain how reimbursement decisions affect real care. Sharing those experiences with policymakers and supporting organized advocacy helps demonstrate that access is not an abstract budget issue. It determines whether a patient receives a timely risk assessment or waits until symptoms become impossible to ignore.
A sustainable prevention system requires a clear public commitment to early detection. Supporting patient access advocacy helps preserve the voice of clinicians and communities affected by Medicare payment decisions. When patients, physicians, and policymakers recognize the value of preventive cardiology, reimbursement can better reflect the care that keeps people healthy, independent, and out of the hospital.
Campaign for Patient Access